Host: Rabbit
Target Protein: HRH1
Immunogen Range: 141-240/487
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 3269
Swiss Prot: P35367
Source: KLH conjugated synthetic peptide derived from human HRH1
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
FCM(1:20-100)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
Predicted Molecular Weight: 54
Cross Reactive Species: Human
Predicted Cross Reactive Species:
Mouse
Rat
Dog
Cow
Pig
For research use only. Not intended for diagnostic or therapeutic use.
- Møller, M. Nue, et al. "Expression of histamine receptors in the human endolymphatic sac: the molecular rationale for betahistine use in Menieres disease." European Archives of Oto-Rhino-Laryngology: 1-6.Read more>>
- Girodet et al. Alternative Macrophage Activation Is Increased in Asthma. (2016) Am.J.Respir.Cell.Mol.Biol. 55:467-475Read more>>
- Aya Sato. et al. Histamine depolarizes rat intracardiac ganglion neurons through the activation of TRPC non-selective cation channels. Eur J Pharmacol. 2020 Nov;886:173536Read more>>
- Liao, Xiaodan. et al. Fullerene nanoparticles for the treatment of ulcerative colitis. 2021 Nov 02Read more>>
- Kristine Elisabeth Eberhard. et al. Neurotransmitter and Neurotransmitter Receptor Expression in the Saccule of the Human Vestibular System. Prog Neurobiol. 2022 Jan;:102238Read more>>
- Yu Wen-Yan. et al. Acupuncture Alleviates Menstrual Pain in Rat Model via Suppressing Eotaxin/CCR3 Axis to Weak EOS-MC Activation. Evid-Based Compl Alt. 2022;2022:4571981Read more>>
Lane 1: Human U87MG cell lysates; Lane 2: Human U251 cell lysates; Lane 3: Human Huvec cell lysates; Lane 4: Human Hela cell lysates probed with HRH1 Polyclonal Antibody, Unconjugated (bs-6663R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.